Search - tctmd.com

Displaying 221 - 240 of 567

Sort: Relevancy | Date

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Industry News

QT Vascular Announces The Allowance Of Four New Patents

July 15, 2015

News Daily News

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

L.A. McKeown

July 01, 2015

News Daily News

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

Yael L. Maxwell

June 26, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

News Daily News

La Neoaterosclerosis Intra Stent se asocia al Avance de la Placa en Arterias No Tratadas

June 16, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Daily News

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

L.A. McKeown

June 10, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

L.A. McKeown

June 03, 2015

Advertisement

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

QT Vascular wins CE Mark for drug-coated balloon

COMPARE:5 年时 EES 的疗效仍优于 PES

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

COMPARE: EES Maintains Advantage Over PES at 5 Years

QT Vascular Announces The Allowance Of Four New Patents

RIBS IV: Los SLE Superan a los BRF en el Manejo de la Reestenosis Intra-Stent

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

RIBS IV：EES 支架内再狭窄治疗效果超越 DCB

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

LEVANT 2：DCB 治疗股腘动脉疾病的 1 年随访结果优于标准球囊成形术

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

La Neoaterosclerosis Intra Stent se asocia al Avance de la Placa en Arterias No Tratadas

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

Meta-analysis Confirms Late Safety of Second-Generation DES

ISAR-DESIRE 3: Un Balón Recubierto de Fármaco Confiere un Efecto Reestenótico Duradero en la Reestenosis del SLF

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content